Advertisement
Hearing loss is linked to several factors associated with menopause

HRT May Increase Risk of Postmenopausal Hearing Loss

0
Older age at menopause also appears to increase the risk
Flibanserin (Addyi) may improve some measures of sexual dysfunction in premenopausal women

AUA: Flibanserin Shows Promise for Sexual Dysfunction in Females

0
Patients noted improvements in desire, arousal, lubrication, orgasm, satisfaction, and pain
Long-term quinine exposure is associated with increased mortality

Quinine Exposure Linked to All-Cause Mortality

0
Increased risk of death more pronounced among those younger than 50 years regardless of indication
Multidisciplinary collaborative care with pharmacist follow-up is beneficial for Asian patients with uncontrolled type 2 diabetes

Pharmacist-Involved Collaborative Care Benefits T2DM

0
Mean reduction of HbA1c in intervention arm with multidisciplinary care and pharmacist follow-up
A considerable proportion of elderly patients with a nonbacterial acute upper respiratory tract infection are prescribed antibiotics

Many Seniors With Nonbacterial Acute URI Prescribed Antibiotics

0
46 percent of patients received antibiotic prescription; 69.9 percent for broad-spectrum agents
The dopamine receptor antagonist domperidone

Warning Against Domperidone Use for Lactating Women

0
Limited evidence for effectiveness, but considerable information on cardiac risks of domperidone
An experimental nasal spray

Novel Nasal Spray Successfully Treats Paroxysmal SVT

0
First nasal spray therapy successful in treating paroxysmal supraventricular tachycardia
Daily topical latanoprost may help stop progression of myopia

ARVO: Latanoprost Halts Myopia Progression in Animal Study

0
Latanoprost effective for lowering IOP, slowing myopia progression in myopia model
In a clinical practice guideline update published online May 9 in the Annals of Internal Medicine

ACP: Recommendations Updated for Low Bone Density Treatment

0
Osteoporotic women should be treated with pharmacologic therapy for 5 years to cut fracture risk
Selective activation of estrogen receptor α activation function-1 prevents obesity

Activation of Estrogen Receptor α-AF1 May Target Adiposity

0
ERα-AF1 agonist tamoxifen could reduce food intake and prevent adiposity, insulin resistance, steatosis